A Washington-based biomedical analysis firm alleges {that a} trio of world-renowned medical establishments in Massachusetts have made unauthorized modifications to proprietary diagnostic exams it designed, which the plaintiff says infringes on its copyrights and probably places the well being of scientific trial contributors in jeopardy.
Trending
- ABC News and CBS News See Gains Before Holiday Weekend
- Shilpa Shetty Kundra has two breakfasts on these days, and ‘butter’ is an essential part of it: ‘I like to keep it natural’ | Food-wine News
- ‘No Further Action’: NY Attorney Grievance Committee Repeatedly Declined to Investigate Emil Bove
- Why Energy Medicine Is Shaping the Next Wave of Leadership Performance
- CNN Only Network with Top Show in Primetime
- Best Thiruvonam Wishes, Messages, Quotes, Images, Greetings, GIF Pics, Photos, Facebook & WhatsApp Status To Share
- Is the Rise of AI a Real Threat to Associate Jobs?
- How to Build a Reputation That Survives Any Crisis
Friday, September 5
Research Firm Claims Dana-Farber Cancer Institute and Others Improperly Modified its Diagnostic Tests
